Agilent Technologies A introduced an advanced gas chromatography/mass spectrometry (GC/MS) column technology product namely J&W 5Q GC/MS Columns, in order to expand its Life Sciences and Applied Markets (LSAG) segment.
The new GC/MS columns are designed to enhance GC/MS workflows and boost system performance in challenging conditions.
With the help of J&W 5Q GC/MS Columns, Agilent strives to meet the demands of modern analytical laboratories. The new columns reduce the frequency of column changes and improve data quality, which helps boost laboratory efficiency and reduce operational costs.
Expanding LSAG Segment Aids Prospect
Apart from the launch of J&W 5Q GC/MS Columns, A recently unveiled two new products — the Agilent 7010D Triple Quadrupole GC-MS System and the Agilent ExD Cell.
The Agilent 7010D Triple Quadrupole GC/MS System, featuring the HES 2.0 ion source, offers robustness and uptime. The Agilent ExD Cell for 6545XT AdvanceBio LC/ quadrupole time-of-flight (Q-TOF) enhances peptide and protein characterization capabilities with electron capture dissociation (ECD).
The company also introduced the Advanced Dilution System (ADS) 2 to address the problems of auto-dilution adoption. The ADS 2 enhances workflow efficiency within the laboratory by integrating with Agilent auto-samplers, ICP-OES and ICP-MS instruments and software.
On the back of expanding LSAG offerings, the company is well-poised to gain solid traction across liquid chromatography (LC) systems, LCMS systems, GC systems and GC/MS systems.
Agilent Technologies, Inc. Price and Consensus
Agilent Technologies, Inc. price-consensus-chart | Agilent Technologies, Inc. Quote
The Bottom Line
Strengthening the LSAG segment, in turn, will aid the company’s overall financial performance in the days ahead.
However, the underlined segment is suffering from macroeconomic uncertainties, a challenging market environment and cost discipline.
Broad-based weakness across all end markets, especially in the Pharma, Food and Academic and Government markets and a softening demand in China are expected to hurt the company’s prospects. Agilent’s shares have inched up 1.4% in the year-to-date period compared with the Zacks Computer & Technology sector’s 23% growth.
For the fiscal 2024, management revised revenue guidance downward from $6.71-$6.81 billion to $6.42-$6.50 billion, suggesting a fall of 6-4.9% on a reported basis and 5.4-4.3% on a core basis from the fiscal 2023 reported figure. The Zacks Consensus Estimate for fiscal 2024 total revenues is pegged at $6.46 billion, indicating a year-over-year decline of 5.47%.
The company also revised fiscal 2024 non-GAAP earnings per share guidance downward from $5.44-$5.55 to $5.15-$5.25. The consensus mark for the same is pegged at $5.19, indicating a year-over-year decline of 4.6%. The figure has moved downward by 0.4% in the past 30 days.
Zacks Rank & Stocks to Consider
Agilent Technologies currently carries a Zacks Rank #4 (Sell).
Some better-ranked stocks in the broader technology sector are Arista Networks ANET, Audioeye AEYE and Badger Meter BMI, each sporting a Zacks Rank #1(Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here
Arista Networks’ shares have gained 49.5% in the year-to-date period. The long-term earnings growth rate for ANET is pegged at 17.20%.
Audioeye’s shares have surged 331.6% in the year-to-date period. The long-term earnings growth rate for Audioeye is currently projected at 25%.
Badger Meter’s shares have gained 31.8% in the year-to-date period. The long-term earnings growth rate for Badger Meter is 17.91%.
Research Chief Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpBadger Meter, Inc. (BMI) : Free Stock Analysis Report
Agilent Technologies, Inc. (A) : Free Stock Analysis Report
Arista Networks, Inc. (ANET) : Free Stock Analysis Report
Audioeye, Inc. (AEYE) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
